Brief: Oragenics Appoints Seasoned Vaccine Executive Kimberly Murphy As President And Chief Executive Officer
23/06/2022 21:44
June 23 (Reuters) - Oragenics Inc OGEN.A :
* ORAGENICS APPOINTS SEASONED VACCINE EXECUTIVE KIMBERLY
MURPHY AS
PRESIDENT AND CHIEF EXECUTIVE OFFICER
* ORAGENICS INC - APPOINTMENT OF MS. KIMBERLY M. MURPHY,
MEMBER OF
BOARD OF DIRECTORS, AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
EFFECTIVE JUNE 23, 2022
Source text for Eikon: ID:nBw2prf3da
Further company coverage: OGEN.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing